CS220306B2 - Method of manufacturing tablets having short breakdown period - Google Patents

Method of manufacturing tablets having short breakdown period Download PDF

Info

Publication number
CS220306B2
CS220306B2 CS75927A CS92775A CS220306B2 CS 220306 B2 CS220306 B2 CS 220306B2 CS 75927 A CS75927 A CS 75927A CS 92775 A CS92775 A CS 92775A CS 220306 B2 CS220306 B2 CS 220306B2
Authority
CS
Czechoslovakia
Prior art keywords
weight
mixture
minutes
tablet
tablets
Prior art date
Application number
CS75927A
Other languages
Czech (cs)
English (en)
Inventor
Allan J Torode
David Harden
John Spence
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS220306(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CS220306B2 publication Critical patent/CS220306B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS75927A 1974-02-14 1975-02-13 Method of manufacturing tablets having short breakdown period CS220306B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (1)

Publication Number Publication Date
CS220306B2 true CS220306B2 (en) 1983-03-25

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
CS75927A CS220306B2 (en) 1974-02-14 1975-02-13 Method of manufacturing tablets having short breakdown period

Country Status (32)

Country Link
JP (1) JPS5545043B2 (no)
AT (1) AT344915B (no)
AU (1) AU468465B2 (no)
BE (1) BE825496A (no)
CA (1) CA980688A (no)
CH (1) CH618432A5 (no)
CS (1) CS220306B2 (no)
CY (1) CY1052A (no)
DD (1) DD118228A5 (no)
DE (1) DE2506099C2 (no)
DK (1) DK143247C (no)
DO (1) DOP1979002763A (no)
ES (1) ES434688A1 (no)
FI (1) FI62219C (no)
FR (1) FR2260993B1 (no)
GB (1) GB1499672A (no)
GT (1) GT197960431A (no)
HK (1) HK23980A (no)
HU (1) HU171536B (no)
IE (1) IE40599B1 (no)
IL (1) IL46629A (no)
IN (1) IN141019B (no)
KE (1) KE3038A (no)
LU (1) LU71835A1 (no)
MC (1) MC1053A1 (no)
MY (1) MY8100054A (no)
NL (1) NL157501C (no)
NO (1) NO146043C (no)
PH (1) PH14575A (no)
SE (1) SE427898B (no)
ZA (1) ZA75930B (no)
ZM (1) ZM1875A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
NO146043B (no) 1982-04-13
JPS5545043B2 (no) 1980-11-15
FR2260993A1 (no) 1975-09-12
GB1499672A (en) 1978-02-01
GT197960431A (es) 1981-05-05
HK23980A (en) 1980-05-09
ES434688A1 (es) 1977-04-01
HU171536B (hu) 1978-01-28
DK143247B (da) 1981-08-03
DE2506099C2 (de) 1983-11-03
NL7501680A (nl) 1975-08-18
PH14575A (en) 1981-09-24
CY1052A (en) 1980-08-01
IL46629A0 (en) 1975-05-22
DK52875A (no) 1975-10-06
CA980688A (en) 1975-12-30
IE40599B1 (en) 1979-07-04
JPS50116627A (no) 1975-09-12
DOP1979002763A (es) 1987-06-18
KE3038A (en) 1980-04-25
DE2506099A1 (de) 1975-08-21
IN141019B (no) 1977-01-08
AU7817075A (en) 1976-01-15
ZA75930B (en) 1976-01-28
MY8100054A (en) 1981-12-31
FI62219C (fi) 1982-12-10
DD118228A5 (no) 1976-02-20
IE40599L (en) 1975-08-14
AU468465B2 (en) 1976-01-15
CH618432A5 (en) 1980-07-31
ATA108475A (de) 1977-12-15
ZM1875A1 (en) 1975-12-22
BE825496A (fr) 1975-05-29
DK143247C (da) 1981-11-30
NL157501C (nl) 1981-07-16
NO146043C (no) 1982-08-04
MC1053A1 (fr) 1976-02-20
SE427898B (sv) 1983-05-24
FR2260993B1 (no) 1978-06-30
LU71835A1 (no) 1975-06-24
IL46629A (en) 1977-07-31
FI62219B (fi) 1982-08-31
SE7501595L (no) 1975-08-15
NO750467L (no) 1975-08-15
FI750398A (no) 1975-08-15
AT344915B (de) 1978-08-25
NL157501B (nl) 1978-08-15

Similar Documents

Publication Publication Date Title
US4950484A (en) Pharmaceutical tablet, pharmaceutical granulate and process for their preparation
KR0136279B1 (ko) 일정수분을 함유하는 서방형 제제
US4261970A (en) Theophylline sustained release granule
CN103083672A (zh) 与其它抗糖尿病药组合的dpp-iv抑制剂、包含此类制剂的片剂，和其用途和制备方法
RU2001115716A (ru) Твердый фармацевтический препарат, содержащий ингибитор hmg-coa-редуктазы
US4209513A (en) Tablet formulation
CN104382868B (zh) 口腔可分散的甘露醇
CZ20022429A3 (cs) Glyburidová kompozice
EA000361B1 (ru) Способ приготовления гранулята, содержащего активный при пероральном введении бета-лактамный антибиотик
EA028676B1 (ru) Спрессованный моксифлоксацин
TW201023897A (en) Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
CS220306B2 (en) Method of manufacturing tablets having short breakdown period
WO2006109175A2 (en) Solid dosage form of an antidiabetic drug
US5322698A (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
CN101631549B (zh) 贴附于口腔粘膜的丁丙诺非制剂的制造方法
US20110229527A1 (en) Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
CN104337787B (zh) 含有利伐沙班的药物制剂
CN100479808C (zh) 贝特类片剂及其制备方法
EP2471520A1 (en) Pharmaceutical compositions of levetiracetam
IE42952B1 (en) Tablet formulation
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
JPH05139973A (ja) ニフエジピン含有固形製剤の製造方法
JPH11130663A (ja) 水難溶性成分を配合した固形剤
RU2190403C1 (ru) Фармацевтическая композиция, обладающая антибактериальным действием, и способ ее получения
Kristoffersson et al. In Vitro Availability of Nitrofurantoin from Different Tablet Batches